SUVOREXANT vs TAFASITAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SUVOREXANT vs TAFASITAMAB: Safety Overview
| Metric | SUVOREXANT | TAFASITAMAB |
|---|---|---|
| Total FAERS Reports | 9,413 | 1,392 |
| Deaths Reported | 219 | 475 |
| Death Rate | 2.3% | 34.1% |
| Hospitalizations | 572 | 433 |
| Average Patient Age | 62.6 yrs | 70.0 yrs |
| % Female Patients | 62.4% | 50.1% |
| FDA Approval Date | Aug 13, 2014 | N/A |
| Manufacturer | Merck Sharp & Dohme LLC | Incyte Corporation |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |